The ESMO Sarcoma and Rare Cancers Congress 2025 will provide insights into the diagnosis, prognostication, management and ongoing research of patients with rare adult solid cancers.
This is an important occasion to promote the value of your products and services.
Download the ESMO Sarcoma and Rare Cancers Congress 2025 Exhibitor Manual
Download the ESMO Sarcoma and Rare Cancers Congress 2025 Floorplan
Contacts
Exhibition Support
ESMO Sarcoma and Rare Cancers Congress 2025 Secretariat
ESMO Head Office
Tel: +41 (0)91 973 19 62
E-mail: meetings@esmo.org
Official Italian agency for AIFA procedure
AIFA rules are mandatory only for Italian Pharmaceutical Companies that will attend a congress abroad.
Any pharmaceutical company supporting or participating in a congress, is subjected to an authorisation by AIFA (Italian Drug Agency), according to an Italian Government Decree (Decreto Legislativo 219/06 – art. 124). The request of authorisation must be submitted within 60 days before the starting date of the event.
ESMO advises pharmaceutical companies to contact the Official Agency:
AIM Group International – AIM Education S.r.l.
Contact: Cristina Ghidoli
Via G. Ripamonti, 129
20141 Milan – Italy
Tel.: +39 02 56601 1
Fax.: +39 02 70048585
E-mail: aifa@aimgroup.eu